Session » Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life

Date: Monday, November 14, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1817

A Longitudinal Analysis of Change in Lupus Disease Activity Pattern in Hopkins Lupus Cohort Using a Multistate Markov Model Approach

9:00AM-11:00AM: Abstract Number: 1790

Accrual of Disease Comorbidities over 8 Years in a Multicentre Inception SLE Cohort

9:00AM-11:00AM: Abstract Number: 1806

Adherence to Treatment and Social, Educational Levels in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1788

Alterations in Sense of Smell and Limbic Structures in Patients with Systemic Lupus Erythematosus during 3-Years Follow-up

9:00AM-11:00AM: Abstract Number: 1781

Analysis of Influences of Various Factors on the Prognosis of Acute Confusional State of Diffuse Psychiatric/Neuropsychological Syndromes in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1776

Analysis of Progressive Brain and Corpus Callosum Atrophy and Association with Th1 and Th2 Cytokines in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1757

Association of the Lupus Low Disease Activity State (LLDAS) with Health-Related Quality of Life

9:00AM-11:00AM: Abstract Number: 1792

Cardiac Surgery in Systemic Lupus Erythematosus Patients: Clinical Characteristics and Outcomes

9:00AM-11:00AM: Abstract Number: 1774

Chronological Analysis of Damage Accrual in Patientes with Systemic Lupus Erythematosus: Results from the Spanish Registry of Patients with SLE of the Spanish Society of Rheumatology (RELESSER)

9:00AM-11:00AM: Abstract Number: 1801

Clinical Implications of Persistent Sinus Tachycardia in Systemic Lupus Erythematous: A Retrospective Study

9:00AM-11:00AM: Abstract Number: 1771

Depression Is Associated with a Poorer with Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1778

Differences Between Early and Late Cardiovascular Disease in a Population-Based Cohort of Systemic Lupus Erythematosus Patients

9:00AM-11:00AM: Abstract Number: 1764

Effect of Disease Remission on Organ Damage and Quality of Life in Chinese Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1814

Epidemiology and Microbiology of Pneumonia in Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 1805

Factors Associated with Complete Remission in Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study in One Center

9:00AM-11:00AM: Abstract Number: 1769

Fatigue in Anti-Nuclear Antibody Positive Individuals with Insufficient Criteria to Diagnose a Systemic Autoimmune Rheumatic Disease

9:00AM-11:00AM: Abstract Number: 1761

Fatigue in Patients with Systemic Lupus Erythematosus Is Independent of Their Disease Activity but Dependent on Their Damage Accrual and Body Mass Index

9:00AM-11:00AM: Abstract Number: 1768

Fatigue in SLE Is Associated with Neuropsychiatric Involvement, Pain, Impaired Sleep and a Reduced Quality of Life

9:00AM-11:00AM: Abstract Number: 1795

Four Years Follow-up of Subclinical Atherosclerosis in Systemic Lupus Erythematosus Patients

9:00AM-11:00AM: Abstract Number: 1808

Frequency and Factors Associated with Thirty Day Hospital Readmissions Among Systemic Lupus Erythematosus Patients in a Community Hospital in the California Central Valley

9:00AM-11:00AM: Abstract Number: 1815

Frequency and Predictors of Attaining the Lupus Low Disease Activity State (LLDAS) in a Multinational SLE Cohort from the Asia Pacific

9:00AM-11:00AM: Abstract Number: 1803

General Features of SLE Patients Presenting with Autoimmune Hemolytic Anemia

9:00AM-11:00AM: Abstract Number: 1810

Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth

9:00AM-11:00AM: Abstract Number: 1789

Herpetic Viruses in Lupus

9:00AM-11:00AM: Abstract Number: 1766

Impact of Depression on SLE Flares

9:00AM-11:00AM: Abstract Number: 1812

Impact of Severe Organic CNS Involvement in Cognitive Function in a Cohort of Systemic Lupus Erythematosus Patients

9:00AM-11:00AM: Abstract Number: 1787

Increased Heart Rate Variability Reflects Improvement in Clinical Status of Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1809

Influence of Solar Radiation in Cutaneous Manifestations of Lupus: Data from the Gladel Cohort

9:00AM-11:00AM: Abstract Number: 1786

Long-Term Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus in a Large Case Control Cohort Study

9:00AM-11:00AM: Abstract Number: 1763

Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients with Systemic Lupus Erythematosus Following 7 Years of Treatment Exposure: Impact of Clinical Characteristics over Time

9:00AM-11:00AM: Abstract Number: 1791

Loss of Elbow Hyperextension in Females with Early Rheumatologic Disease Was Common in Systemic Lupus Erythematosus and Rheumatoid Arthritis but Rare in Fibromyalgia

9:00AM-11:00AM: Abstract Number: 1765

Minimal Clinically Important Differences for Generic Patient Reported Outcomes Tools in SLE

9:00AM-11:00AM: Abstract Number: 1819

Myocarditis in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1796

Osteoporosis and Vertebral Fractures in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1783

Phenome-Wide Association Study Identifies a New Association of Atrial Fibrillation in Males with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1758

Physical Activity and Sedentary Behaviour in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1767

Poor Body Image in Lupus: Is It Disease Activity, Damage, Sleep, Pain, Fatigue, Stress, Function, Medications, Depression or Fibromyalgia?

9:00AM-11:00AM: Abstract Number: 1818

Predictors for Mortality in Hospitalized Patients with Systemic Lupus Erythematosus from 1999 to 2009: A Follow-up Multicenter Study in China

9:00AM-11:00AM: Abstract Number: 1785

Prevalence and Associated Factors of Low Bone Mass in Adults with Systemic Lupus Erythmatosus

9:00AM-11:00AM: Abstract Number: 1813

Prevalence and Incidence of Systemic Lupus Erythematosus in Tucuman -Argentina

9:00AM-11:00AM: Abstract Number: 1802

Prevalence of CMV in the Ohio State University Lupus Population

9:00AM-11:00AM: Abstract Number: 1800

Prevalence of ECG Cardiovascular Abnormalities in Lupus Patients: A Novel Approach Using 5 ECG Elements

9:00AM-11:00AM: Abstract Number: 1807

Prevalence of Progressive Multifocal Leukoencephalopathy in Adults and Children with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1804

Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: a Single Centre Experience

9:00AM-11:00AM: Abstract Number: 1780

Pulmonary Disease in Late Versus Early Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1779

Remission and Low Lupus Disease Activity Status (LLDAS) Protect Lupus Patients from Damage Occurrence: Data from a Multi-Ethnic, Multinational Latin American Lupus Cohort

9:00AM-11:00AM: Abstract Number: 1773

Risk Factors for Cerebrovascular Events in Systemic Lupus Erythematosus: Results from an International, Inception Cohort Study

9:00AM-11:00AM: Abstract Number: 1798

Risk Factors for Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review

9:00AM-11:00AM: Abstract Number: 1797

Seasonal Differences in the Disease Onset and the Exacerbation of Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1816

SLE and Uctd in the Rheumatology Informatics System for Effectiveness (RISE) Registry

9:00AM-11:00AM: Abstract Number: 1759

Sleep Disturbance Is Associated with Worsening Patient-Reported Outcomes over Two Years in Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 1775

Smoking As a Predictor of Cutaneous Activity in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1799

Smoking, Antiphospholipid Antibodies and Thrombosis in SLE

9:00AM-11:00AM: Abstract Number: 1782

Subclinical Myocarditis in Systemic Lupus Erythematosus Patients without Cardiovascular Disease

9:00AM-11:00AM: Abstract Number: 1762

Systemic Lupus Erythematosus and the Evaluation of Poor Sleep

9:00AM-11:00AM: Abstract Number: 1760

Systemic Lupus Erythematosus in Immigrants: Results from the 1000 Canadian Faces of Lupus Study

9:00AM-11:00AM: Abstract Number: 1811

Systemic Lupus Erythematosus: Detailed Anatomy of a Cohort (follow-up for more than 35 years).

9:00AM-11:00AM: Abstract Number: 1777

The Accumulation of Organ Damage, Public Insurance Enrollment and Youth Are Associated with Increased Hospitalizations in a Population-Based Cohort of Lupus Patient

9:00AM-11:00AM: Abstract Number: 1794

The High Disease Activity State Is an Adverse Prognostic Indicator in SLE and Defines a Clinically Distinct Population

9:00AM-11:00AM: Abstract Number: 1770

The Impact of Comorbidities on Quality of Life in Systemic Lupus Erythematosus in the First 10 Years

9:00AM-11:00AM: Abstract Number: 1784

The Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Lupus Erythematosus: A Population-Based Study

9:00AM-11:00AM: Abstract Number: 1793

Visceral Adiposity Assessed By DXA in Juvenile-Onset Systemic Lupus Erythematosus: A Correlation with Damage Index and Disease Duration

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].